Signaling Pathways of ESE-16, an Antimitotic and Anticarbonic Anhydrase Estradiol Analog, in Breast Cancer Cells

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Stander, Barend Andre ^a   Joubert, Fourie ^a   Tu, Chingkuang ^b   Sippel, Katherine H ^c   McKenna, Robert ^d   Joubert, Annie Margaretha ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYL 3 O SULPHAMOYL ESTRA 1,3,5(10)16 TETRAENE; ANTIMITOTIC AGENT; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE INHIBITOR; CARBONATE DEHYDRATASE IX; CASPASE 3; CASPASE 7; ESTRADIOL DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BCL 2; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL DAMAGE; CELL MEMBRANE DEPOLARIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME INHIBITION; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IRON METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; UNINDEXED SEQUENCE;

APOPTOSIS; AUTOPHAGY; CARBONIC ANHYDRASE II; CELL CYCLE CHECKPOINTS; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE KINASE 4; MCF-7 CELLS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 84873136745     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053853     Document Type: Article

References (67)

1. Bughani U, Li S, Joshi HC, (2009) Recent patents reveal microtubules as persistent promising target for novel drug development for cancers. Recent Pat Antiinfect Drug Discov 4: 164-182.
2. Newman SP, Ireson CR, Tutill HJ, Day JM, Parsons MF, et al. (2006) The role of 17beta-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells. Cancer Res 66: 324-330.
3. Ireson CR, Chander SK, Purohit A, Perera S, Newman SP, et al. (2004) Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents. Br J Cancer 90: 932-937.
4. Supuran CT, Scozzafava A, (2007) Carbonic anhydrases as targets for medicinal chemistry. Bioorganic & Medicinal Chemistry 15: 4336-4350.
5. Snoeks TJ, Mol IM, Que I, Kaijzel EL, Lowik CW, (2011) 2-methoxyestradiol analogue ENMD-1198 reduces breast cancer-induced osteolysis and tumor burden both in vitro and in vivo. Molecular Cancer Therapeutics 10: 874-882.
6. Zhou Q, Gustafson D, Nallapareddy S, Diab S, Leong S, et al. (2011) A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer. Invest New Drugs 29: 340-346.
7. Pasquier E, Sinnappan S, Munoz MA, Kavallaris M, (2010) ENMD-1198, a new analogue of 2-methoxyestradiol, displays both antiangiogenic and vascular-disrupting properties. Molecular Cancer Therapeutics 9: 1408-1418.
8. Moser C, Lang SA, Mori A, Hellerbrand C, Schlitt HJ, et al. (2008) ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo. BMC Cancer 8: 206.
9. LaVallee TM, Burke PA, Swartz GM, Hamel E, Agoston GE, et al. (2008) Significant antitumor activity in vivo following treatment with the microtubule agent ENMD-1198. Molecular Cancer Therapeutics 7: 1472-1482.
10. Agoston GE, Shah JH, Suwandi L, Hanson AD, Zhan X, et al. (2009) Synthesis, antiproliferative, and pharmacokinetic properties of 3- and 17-double-modified analogs of 2-methoxyestradiol. Bioorg Med Chem Lett 19: 6241-6244.
11. Stander A, Joubert F, Joubert A, (2011) Docking, synthesis, and in vitro evaluation of antimitotic estrone analogs. Chemical Biology & Drug Design 77: 173-181.
12. Fukumura D, Jain RK, (2007) Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem 101: 937-949.
13. Pastorekova S, Ratcliffe PJ, Pastorek J, (2008) Molecular mechanisms of carbonic anhydrase IX-mediated pH regulation under hypoxia. BJU Int 101Suppl 4: 8-15.
14. Rofstad EK, Mathiesen B, Kindem K, Galappathi K, (2006) Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res 66: 6699-6707.
15. Robertson N, Potter C, Harris AL, (2004) Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion. Cancer Res 64: 6160-6165.
16. Sly WS, Hu PY, (1995) Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 64: 375-401.
17. Matson DR, Stukenberg PT, (2011) Spindle poisons and cell fate: a tale of two pathways. Mol Interv 11: 141-150.
18. Silverman DN, (1982) [35] Carbonic anhydrase: Oxygen-18 exchange catalyzed by an enzyme with rate-contributing Proton-transfer steps. Methods in Enzymology 87: 732-752.
19. Segel I (1975) Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems. New York: Wiley-Interscience.
20. Li Y, Wang H, Oosterwijk E, Tu C, Shiverick KT, et al. (2009) Expression and activity of carbonic anhydrase IX is associated with metabolic dysfunction in MDA-MB-231 breast cancer cells. Cancer investigation 27: 613-623.
21. Hall DA, Ptacek J, Snyder M, (2007) Protein microarray technology. Mech Ageing Dev 128: 161-167.
22. Glokler J, Angenendt P, (2003) Protein and antibody microarray technology. J Chromatogr B Analyt Technol Biomed Life Sci 797: 229-240.
23. Boya P, Kroemer G, (2008) Lysosomal membrane permeabilization in cell death. Oncogene 27: 6434-6451.
24. Yuan XM, Li W, Dalen H, Lotem J, Kama R, et al. (2002) Lysosomal destabilization in p53-induced apoptosis. Proceedings of the National Academy of Sciences 99: 6286-6291.
25. Karlsson M, Kurz T, Brunk U, Nilsson S, Frennesson C, (2010) What does the commonly used DCF test for oxidative stress really show? Biochemical Journal 428: 183-190.
26. Guthrie HD, Welch GR, (2008) Determination of high mitochondrial membrane potential in spermatozoa loaded with the mitochondrial probe 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolyl-carbocyanine iodide (JC-1) by using fluorescence-activated flow cytometry. Methods Mol Biol 477: 89-97.
27. Barbouti A, Doulias PT, Zhu BZ, Frei B, Galaris D, (2001) Intracellular iron, but not copper, plays a critical role in hydrogen peroxide-induced DNA damage. Free Radical Biology and Medicine 31: 490-498.
28. Zimmermann KC, Bonzon C, Green DR, (2001) The machinery of programmed cell death. Pharmacology & therapeutics 92: 57-70.
29. Genis C, Sippel KH, Case N, Cao W, Avvaru BS, et al. (2009) Design of a Carbonic Anhydrase IX Active-Site Mimic To Screen Inhibitors for Possible Anticancer Properties. Biochemistry 48: 1322-1331.
30. Sippel K, Stander A, Tu C, Venkatakrishnan B, H Robbins A, et al. (2011) Characterization of Carbonic Anhydrase Isozyme Specific Inhibition by Sulfamated 2-Ethylestra Compounds. Letters in Drug Design and Discovery 8: 678-684.
31. Xie D, Gore C, Zhou J, Pong RC, Zhang H, et al. (2009) DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis. Proc Natl Acad Sci U S A 106: 19878-19883.
32. Wang Z, Tseng CP, Pong RC, Chen H, McConnell JD, et al. (2002) The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2. J Biol Chem 277: 12622-12631.
33. Yu J, Zhang L, (2008) PUMA, a potent killer with or without p53. Oncogene 27Suppl 1: S71-83.
34. Liebermann DA, Tront JS, Sha X, Mukherjee K, Mohamed-Hadley A, et al. (2011) Gadd45 stress sensors in malignancy and leukemia. Crit Rev Oncog 16: 129-140.
35. Liebermann DA, Hoffman B, (2008) Gadd45 in stress signaling. J Mol Signal 3: 15.
36. Vurusaner B, Poli G, Basaga H, (2012) Tumor suppressor genes and ROS: complex networks of interactions. Free Radic Biol Med 52: 7-18.
37. Malhotra JD, Kaufman RJ, (2007) Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal 9: 2277-2293.
38. Oyadomari S, Mori M, (2004) Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death and Differentiation 11: 381-389.
39. Hitomi J, Katayama T, Eguchi Y, Kudo T, Taniguchi M, et al. (2004) Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death. Journal of Cell Biology 165: 347-356.
40. Lew DJ, Burke DJ, (2003) The spindle assembly and spindle position checkpoints. Annu Rev Genet 37: 251-282.
41. Baker DJ, Dawlaty MM, Galardy P, van Deursen JM, (2007) Mitotic regulation of the anaphase-promoting complex. Cell Mol Life Sci 64: 589-600.
42. Yu H, (2002) Regulation of APC-Cdc20 by the spindle checkpoint. Curr Opin Cell Biol 14: 706-714.
43. Peters JM, (2006) The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat Rev Mol Cell Biol 7: 644-656.
44. Stander BA, Marais S, Vorster C, Joubert AM, (2010) In vitro effects of 2-methoxyestradiol on morphology, cell cycle progression, cell death and gene expression changes in the tumorigenic MCF-7 breast epithelial cell line. The Journal of Steroid Biochemistry and Molecular Biology 119: 149-160.
45. Zoubine MN, Weston AP, Johnson DC, Campbell DR, Banerjee SK, (1999) 2-methoxyestradiol-induced growth suppression and lethality in estrogen-responsive MCF-7 cells may be mediated by down regulation of p34cdc2 and cyclin B1 expression. Int J Oncol 15: 639-646.
46. Van Zijl C, Lottering ML, Steffens F, Joubert A, (2008) In vitro effects of 2-methoxyestradiol on MCF-12A and MCF-7 cell growth, morphology and mitotic spindle formation. Cell Biochem Funct 26: 632-642.
47. Attalla H, Makela TP, Adlercreutz H, Andersson LC, (1996) 2-Methoxyestradiol arrests cells in mitosis without depolymerizing tubulin. Biochem Biophys Res Commun 228: 467-473.
48. Lew DJ, Burke DJ, (2003) The spindle assembly and spindle position checkpoints. Annual Review of Genetics 37: 251-282.
49. Logarinho E, Resende T, Torres C, Bousbaa H, (2008) The human spindle assembly checkpoint protein Bub3 is required for the establishment of efficient kinetochore-microtubule attachments. Molecular Biology of the Cell 19: 1798-1813.
50. Rubin CI, Atweh GF, (2004) The role of stathmin in the regulation of the cell cycle. J Cell Biochem 93: 242-250.
51. Morse D, Lin L, Choi AM, Ryter SW, (2009) Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease. Free Radic Biol Med 47: 1-12.
52. Torti FM, Torti SV, (2002) Regulation of ferritin genes and protein. Blood 99: 3505-3516.
53. Keyse SM, Tyrrell RM, (1989) Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci U S A 86: 99-103.
54. Ryter SW, Si M, Lai CC, Su CY, (2000) Regulation of endothelial heme oxygenase activity during hypoxia is dependent on chelatable iron. Am J Physiol Heart Circ Physiol 279: H2889-2897.
55. Liochev SI, Fridovich I (2002) The Haber-Weiss cycle -70 years later: an alternative view. Redox Rep 7: 55-57; author reply 59-60.
56. Hasan MR, Koikawa S, Kotani S, Miyamoto S, Nakagawa H, (2006) Ferritin forms dynamic oligomers to associate with microtubules in vivo: implication for the role of microtubules in iron metabolism. Experimental cell research 312: 1950-1960.
57. Bresgen N, Jaksch H, Lacher H, Ohlenschläger I, Uchida K, et al. (2010) Iron-mediated oxidative stress plays an essential role in ferritin-induced cell death. Free Radical Biology and Medicine 48: 1347-1357.
58. Fujino G, Noguchi T, Takeda K, Ichijo H, (2006) Thioredoxin and protein kinases in redox signaling. Seminars in cancer biology 16: 427-435.
59. Yan S, Qu X, Xu C, Zhu Z, Zhang L, et al. (2012) Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells. Journal of cancer research and clinical oncology: 1-11.
60. Sunters A, Madureira PA, Pomeranz KM, Aubert M, Brosens JJ, et al. (2006) Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt. Cancer research 66: 212-220.
61. Yu Z, Persson HL, Eaton JW, Brunk UT, (2003) Intralysosomal iron: a major determinant of oxidant-induced cell death. Free Radical Biology and Medicine 34: 1243-1252.
62. Boya P, Andreau K, Poncet D, Zamzami N, Perfettini JL, et al. (2003) Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. The Journal of experimental medicine 197: 1323-1334.
63. Sadowski-Debbing K, Coy JF, Mier W, Hug H, Los M, (2002) Caspases-their role in apoptosis and other physiological processes as revealed by knock-out studies. Arch Immunol Ther Exp (Warsz) 50: 19-34.
64. Kurokawa H, Nishio K, Fukumoto H, Tomonari A, Suzuki T, et al. (1999) Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells. Oncol Rep 6: 33-37.
65. Letai A, Kutuk O, (2008) Regulation of Bcl-2 family proteins by posttranslational modifications. Current Molecular Medicine 8: 102-118.
66. Galaris D, Pantopoulos K, (2008) Oxidative stress and iron homeostasis: mechanistic and health aspects. Critical reviews in clinical laboratory sciences 45: 1-23.
67. Shpyleva SI, Tryndyak VP, Kovalchuk O, Starlard-Davenport A, Chekhun VF, et al. (2011) Role of ferritin alterations in human breast cancer cells. Breast cancer research and treatment 126: 63-71.